Medtronic MDT Neuroscience — Currency translation and other
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's neuroscience — currency translation and other.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's neuroscience — currency translation and other?
- Medtronic (MDT) reported neuroscience — currency translation and other of $20M in Q1 2026.
- How has Medtronic's neuroscience — currency translation and other changed year-over-year?
- Medtronic's neuroscience — currency translation and other decreased by 81.1% year-over-year, from $106M to $20M.
- What is the long-term trend for Medtronic's neuroscience — currency translation and other?
- Over 2 years (2021 to 2025), Medtronic's neuroscience — currency translation and other has grown at a -34.3% compound annual growth rate (CAGR), from $167M to $72M.
- What does neuroscience — currency translation and other mean?
- The financial impact of changing currency values and other non-core items on the segment's results.
- How do you interpret neuroscience — currency translation and other?
- A negative value indicates a headwind from a strong domestic currency, while a positive value suggests a tailwind from favorable exchange rate movements.
- How does neuroscience — currency translation and other compare across companies?
- Standard in multinational corporations; comparable to foreign exchange impact disclosures by global healthcare peers.